Nav: Home

Studies reveal looming shortage of rheumatologists

February 05, 2018

Two new articles provide insights on the outlook of rheumatology in the United States, noting that the need for rheumatologists will greatly exceed the projected growth of the rheumatology workforce over the next 15 years. As noted in Arthritis Care & Research, this is due to an increasing aging patient population, a wave of impending baby boomer rheumatologists retiring, and changing practice trends for new rheumatologists. In Arthritis & Rheumatology, experts note that there has been an increase in the number of rheumatology fellowship programs and an increase in the number of fellows being trained in these programs; however, even a doubling of the number of fellows being trained would not meet the projected rheumatology workforce needs in 2030.

In the Arthritis Care & Research study, investigators used a modeling approach incorporating primary and secondary data sources to project supply and demand of the rheumatology workforce--including physicians, nurse practitioners, and physician assistants who diagnose and treat conditions including osteoarthritis, gout, rheumatoid arthritis, lupus, vasculitis, and other autoimmune diseases--through 2030.

The 2015 adult workforce was estimated to be 6013 providers (5415 clinical full-time equivalent [FTE] providers). Estimating the clinical FTE of rheumatology providers is important to better reflect rheumatology providers working full-time seeing patients versus other rheumatology providers who may work as part-time clinicians in private practice or in an academic rheumatology teaching practice. Clinical FTE describes the percentage of work effort devoted to clinical care to reflect a more realistic picture of patient access to care (e.g., two providers each caring for patients 50% of the time would together equate to 1.0 total clinical FTE). By 2030, the supply of rheumatology clinical providers is projected to fall to 4882 providers or 4051 clinical FTE, and demand is projected to exceed supply by 4133 clinical FTE.

The investigators also noted that there is a geographic maldistribution of adult rheumatologists across the United States, and this will worsen in the coming years. For example, 21% of adult rheumatologists were in the Northeast in 2015, compared with only 3.9% in the Southwest. In 2015, the ratio of rheumatology providers per 100,000 patients by region ranged from 3.07 in the Northeast to 1.28 in the Southwest. By 2025, there is an anticipated decrease in this ratio in all regions ranging from 1.61 in the Northeast to 0.50 in the Northwest.

"Decreasing insurance barriers and healthcare regulations may allow more rapid, timely, and creative solutions to offset the projected rheumatologist shortage and the maldistribution of rheumatologists in the United States," said senior author Seetha Monrad, MD, of the University of Michigan. "Based on our projected rheumatology workforce shortages, innovative strategies will be needed to address access to patient care, as it will not be possible to solve the supply-demand gap by training more rheumatologists alone."

In their Arthritis & Rheumatology study, the investigators applied similar modeling methods to adult rheumatology training programs and graduates entering the adult rheumatology workforce. "The supply of rheumatologists in the workforce is dependent upon the training of new rheumatologists to join our specialty," said lead author Marcy Bolster, MD, of Massachusetts General Hospital. "It is imperative to create innovative ways to expand the rheumatology workforce, and this will involve new ways to fund graduate medical education training."

The study found that in 2015, there were 113 adult rheumatology programs with 431 of 468 available positions filled. The projected clinical FTE number entering the workforce each year was 107; this number was impacted significantly by gender and generational trends. For example, men currently comprise 59% of the rheumatology workforce, but the proportion is expected to drop to 43% by 2030. Also, millennials comprise 6% of the current workforce but by 2030, the percentage will rise to 44%. Prior studies have demonstrated that women work 7 fewer hours per week and see 30% fewer patients than men, and both male and female millennials in 2015 saw fewer patients compared with their counterparts in 2005. The study also found that 17% of current fellows who are international medical graduates say they plan to practice outside the United States.

"It is apparent that the workforce expansion innovations will require resources devoted to education and training, and it may be helpful to consider incentives to attract new entrants in the workforce to areas in greatest need of rheumatologists," said senior author Daniel Battafarano, DO, MACP, of the San Antonio Military Medical Center. "Clearly other workforce expansion tactics such as care provided by nurse practitioners and physician assistants, telemedicine, and ensuring that current rheumatology care providers remain in the workforce will be needed as we create a multi-faceted approach to addressing rheumatology workforce needs over the next decade."
-end-
Additional Information

The information contained in this release is protected by copyright. Members of the media may sign up for embargoed news or to request a copy of any study please contact:

Dawn Peters (US)
1 781-388-8408
sciencenewsroom@wiley.com
Follow us on Twitter @WileyNews

Full Citations:

"2015 American College of Rheumatology Workforce Study: Supply and Demand Projections of Adult Rheumatology Workforce (2015-2030)." Daniel F. Battafarano, Marcia Ditmyer, Marcy B. Bolster, John D. FitzGerald, Chad Deal, Anne R. Bass, Rodolfo Molina, Alan R. Erickson, Jonathan S. Hausman, Marisa Klein-Gitelman, Lisa F. Imundo, Benjamin J. Smith, Karla Jones, Kamilah Greene, and Seetha U. Monrad. Arthritis Care & Research; Published Online: February 5, 2018 (DOI: 10.1002/acr.23518).

URL Upon Publication:http://doi.wiley.com/10.1002/acr.23518

"2015 Rheumatology Workforce Study: The Role of Graduate Medical Education in Adult Rheumatology." Marcy B. Bolster, Anne R. Bass, Jonathan S. Hausmann, Chad Deal, Marcia Ditmyer, Kamilah L. Greene, Seetha U. Monrad, and Daniel F. Battafarano. Arthritis & Rheumatology; Published Online: February 5, 2018 (DOI: 10.1002/art.40432).

URL Upon Publication:http://doi.wiley.com/10.1002/art.40432

Editorial: "Ensuring the future of Rheumatology: A multi-dimensional challenge and call to action." William F. Harvey, Afton L. Hassett, Sharad Lakhanpal, Arthritis & Rheumatology; Published Online: February 5, 2018 (DOI: 10.1002/art.40431). URL Upon Publication: http://doi.wiley.com/10.1002/art.40431

Author Contacts:

Dr. Monrad: Michigan Medicine's media office (+1 734-764-2220 or MichMedmedia@med.umich.edu)

Dr. Bolster: Massachusetts General Hospital's Public Affairs office (+1 617-726-2206)

Dr. Battafarano: Elaine Sanchez (elaine.s.sanchez.civ@mail.mil) or Robert Whetstone (robert.a.whetstone.civ@mail.mil)

About the Journals

Arthritis Care & Research is an official journal of the American College of Rheumatology (ACR), and the Association of Rheumatology Health Professionals (ARHP), a division of the College. Arthritis Care & Research is a peer-reviewed journal that publishes both original research and review articles that promote excellence in the clinical practice of rheumatology. Relevant to the care of individuals with arthritis and related disorders, major topics are evidence-based practice studies, clinical problems, practice guidelines, health care economics, health care policy, educational, social, and public health issues, and future trends in rheumatology practice. The journal is published by Wiley on behalf of the ACR. For more information, please visit the journal home page at http://wileyonlinelibrary.com/journal/acr.

Arthritis & Rheumatology is an official journal of the American College of Rheumatology (ACR) and covers all aspects of inflammatory disease. The American College of Rheumatology (http://www.rheumatology.org) is the professional organization whose members share a dedication to healing, preventing disability, and curing the more than 100 types of arthritis and related disabling and sometimes fatal disorders of the joints, muscles, and bones. Members include practicing physicians, research scientists, nurses, physical and occupational therapists, psychologists, and social workers. The journal is published by Wiley on behalf of the ACR. For more information, please visit http://wileyonlinelibrary.com/journal/art.

About Wiley

Wiley, a global research and learning company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical, and scholarly journals, combined with our digital learning, assessment and certification solutions help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 210 years, we have delivered consistent performance to our stakeholders. The company's website can be accessed at http://www.wiley.com.

Wiley

Related Rheumatology Articles:

New guideline aims to reduce infections in total hip & knee replacement patients
According to a new guideline released by the American College of Rheumatology (ACR) and American Association of Hip and Knee Surgeons (AAHKS), the risk of joint infection resulting from total hip and knee replacements can be reduced with careful management of anti-rheumatic medications during the perioperative process.
Biosimilar concerns of rheumatology patients being addressed by national program
To address the fear and insecurity expressed by rheumatology patients on being switched from a biologic to a biosimilar treatment for their arthritis, the Danish Rheumatism Association has participated in a national program designed to ensure patients received independent information about biosimilars, along with closer monitoring of prescriptions to provide reassurance about their safety.
Trial demonstrates benefits of learning sessions for managing rheumatoid arthritis
A new study found that group-based quality improvement sessions help rheumatologists care for rheumatoid arthritis patients with the recommended 'treat to target' (TTT) approach to care.
ACR announces 2017 health policy priorities
The American College of Rheumatology today announced its 2017 health policy priorities, providing detailed policy recommendations to improve access to care for rheumatology patients and address the national rheumatology workforce shortage.
ACR: AHCA does not go far enough to help Americans with rheumatic diseases
American College of Rheumatology President Sharad Lakhanpal, MBBS, M.D., released a statement this morning expressing concern about the American Health Care Act's (AHCA) proposed tax credits system and its failure to include a repeal of the Independent Payment Advisory Board.
'Arthritis 101' Congressional briefing discusses $128 billion impact to healthcare system
Experts from the American College of Rheumatology (ACR) and the Arthritis Foundation today held an 'Arthritis 101' Congressional briefing to educate new and returning Congressional leaders about arthritis and its impact on constituents and the US healthcare system.
Rheumatology leaders say FDA biosimilar interchangeability guidance a balanced approach
The Food and Drug Administration (FDA) has released a draft guidance on biosimilar interchangeability titled 'Considerations in Demonstrating Interchangeability With a Reference Product' that leaders at the American College of Rheumatology (ACR) believe may address many of the safety and efficacy concerns physicians have raised over the past year.
ACR sends letter to Congress outlining health care reform priorities
The American College of Rheumatology sent a letter to Congressional leaders ahead of actions on health policy, urging lawmakers to adopt a health-care reform plan that is consistent with the ACR's priority of affordable and accessible health care for Americans living with rheumatic diseases.
ACR applauds FDA guidance requiring distinct names and suffixes for biosimilars
The American College of Rheumatology today applauded final guidance from the Food and Drug Administration recommending distinct suffixes for biosimilars and reference biologics, which rheumatologists say will be critical to ensuring patient safety and prescriber confidence in the era of biosimilars.
Rheumatology community applauds CMS's decision to scrap Part B payment demo
The American College of Rheumatology today applauded the decision from the Centers for Medicare & Medicaid Services (CMS) not to go forward with the agency's controversial Part B payment proposal, noting that the hard-fought outcome is good news for rheumatology patients who rely on Medicare Part B to access life-saving biologic therapies.

Related Rheumatology Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Bias And Perception
How does bias distort our thinking, our listening, our beliefs... and even our search results? How can we fight it? This hour, TED speakers explore ideas about the unconscious biases that shape us. Guests include writer and broadcaster Yassmin Abdel-Magied, climatologist J. Marshall Shepherd, journalist Andreas Ekström, and experimental psychologist Tony Salvador.
Now Playing: Science for the People

#513 Dinosaur Tails
This week: dinosaurs! We're discussing dinosaur tails, bipedalism, paleontology public outreach, dinosaur MOOCs, and other neat dinosaur related things with Dr. Scott Persons from the University of Alberta, who is also the author of the book "Dinosaurs of the Alberta Badlands".